Although there is growing support for the protective effects of psychedelics on mental health, recent evidence finds racial and ethnic minorities gain fewer benefits. This paper aims to test whether the disparate mental health outcomes associated with psychedelic use extend across multiple racial and ethnic groups, including non-Hispanic Whites, Blacks, Asians, and Hispanics. In order to understand the relationship between race/ethnicity, psychedelics, and mental health, this study draws from the National Survey of Drug Use and Health (NSDUH) data from 2005 to 2019, with a sample size of 596,187 individuals. The study examines the association between various psychedelics (such as MDMA, Psilocybin, DMT, Ayahuasca, Peyote/Mescaline, and LSD) and one measure of Lifetime Classic Psychedelics Use (LCPU) on multiple mental health measures, including depression, suicidal ideation, suicide planning, suicide attempts, psychological distress, and serious mental illness. Additionally, the analysis compares health outcomes between non-Hispanic Whites, non-Hispanic Blacks, non-Hispanic Asians, and Hispanics. A series of nested logistic and ordinary least square regression models are used in the analysis, conducted using Stata 18. The results reveal significant variation in the association between psychedelic use and mental health outcomes. Most notably, there are more instances where psychedelic use is associated with better mental health among non-Hispanic Whites compared to minority populations. Moreover, not only are there fewer associations between psychedelic use and better mental health among Black, Hispanic, and Asian individuals, but there are also just as many instances where psychedelic use is associated with worse mental health, particularly among Black and Asian populations.
ArmstrongRA (2014) When to use the Bonferroni correction. Ophthalmic and Physiological Optics34(5): 502–508.
2.
AssariS (2020) Blacks’ diminished health returns of educational attainment: Health and retirement study. Journal of Medical Research and Innovation4(1): 1–11.
3.
AssariSMistryR (2018) Educational attainment and smoking status in a national sample of American adults; evidence for the blacks’ diminished return. International Journal of Environmental Research and Public Health15(4): 1–12. https://doi.org/10.3390/ijerph15040763.
4.
BenjaminiYYekutieliD (2001) The control of the false discovery rate in multiple testing under dependency. The Annals of Statistics29(4). https://doi.org/10.1214/aos/1013699998.
5.
BowerKMThorpeRJRohdeC, et al. (2014) The intersection of neighborhood racial segregation, poverty, and urbanicity and its impact on food store availability in the United States. Preventive Medicine58(1): 33–39.
6.
BowerKMThorpeRJYenokyanG, et al. (2015) Racial residential segregation and disparities in obesity among women. Journal of Urban Health92(5): 843–852.
7.
BrownTNDonatoKMLaskeMT, et al. (2013) Race, nativity, ethnicity, and cultural influuences in the sociology of mental health. In: AneshenselCSPhelanJCBiermanA (eds) Handbook of the Sociology of Mental Health. SecondDordrecht, Netherlands: Springer Netherlands, 255–276.
8.
ChingTHWWilliamsMTWangJB, et al. (2022) MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two phase 2 open-label lead-in trials and a phase 3 randomized, blinded placebo-controlled trial. Journal of Psychopharmacology36(8): 974–986.
9.
ClemensKJMcGregorISHuntGE, et al. (2007) MDMA, methamphetamine and their combination: Possible lessons for party drug users from recent preclinical research. Drug and Alcohol Review26(1): 9–15.
10.
CollinsPHCollinsPH (2015) Intersectionality’s definitional dilemmas. Annual Review of Public Health41: 1–20.
11.
DavisAKBarrettFSMayDG, et al. (2021) Effects of psilocybin-assisted therapy on Major depressive disorder: A randomized clinical trial. JAMA Psychiatry78(5): 481–489.
12.
Department of Health and Human Services (2001) Mental Health: Culture, Race, and Ethnicity: A Supplement to Mental Health: A Report of the Surgeon General. Department of Health and Human Services.
13.
FaudreeP (2015) Tales from the land of magic plants: Textual ideologies and fetishes of indigeneity in Mexico’s Sierra Mazateca. Comparative Studies in Society and History57(3): 838–869.
14.
FerreiraJAZwindermanAH (2006) On the Benjamini-Hochberg method. Annals of Statistics34(4): 1827–1849.
15.
Garcia-RomeuABarrettFSCarbonaroTM, et al. (2021) Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches. Journal of Psychopharmacology35(4): 353–361.
16.
GaskinDJDinwiddieGYChanKS, et al. (2012) Residential segregation and disparities in health care services utilization. Medical Care Research and Review69(2): 158–175.
17.
GriffithsRRJohnsonMWCarducciMA, et al. (2016) Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology30(12): 1181–1197.
18.
HalpernJHSherwoodARHudsonJI, et al. (2005) Psychological and cognitive effects of long-term peyote use among native Americans. Biological Psychiatry58(8): 624–631.
19.
HendricksPSClarkCBJohnsonMW, et al. (2014) Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision. Journal of Psychopharmacology28(1): 62–66.
20.
HendricksPSCrawfordMSCropseyKL, et al. (2018) The relationships of classic psychedelic use with criminal behavior in the United States adult population. Journal of Psychopharmacology32(1): 37–48.
21.
HendricksPSThorneCBClarkCB, et al. (2015) Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. Journal of Psychopharmacology29(3): 280–288.
22.
JohnstadPG (2021) Who is the typical psychedelics user? Methodological challenges for research in psychedelics use and its consequences. Nordic Studies on Alcohol and Drugs38(1): 35–49.
23.
JonesGM (2023) Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes. Journal of Psychopharmacology37(1): 61–69.
24.
JonesGMNockMK (2022a) MDMA/Ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults. Journal of Psychopharmacology36(1): 46–56.
25.
JonesGMNockMK (2022b) Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA and psilocybin) and psychological distress and suicidality. Scientific Reports37(1): 61–69.
26.
JonesPN (2007) The native American church, peyote, and health: Expanding consciousness for healing purposes. Contemporary Justice Review10(4): 411–425.
27.
KesslerRCAndrewsGColpeLJ, et al. (2002) Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychological Medicine32(6): 959–976.
28.
KesslerRCGreenJGGruberMJ, et al. (2010) Screening for serious mental illness in the general population with the K6 screening scale: Results from the WHO world mental health (WMH) survey initiative. International Journal of Methods in Psychiatric Research19(SUPPL. 1): 4–22.
29.
KimPYKendallDLCheonH-S (2017) Racial microaggressions, cultural mistrust, and mental health outcomes among Asian American college students. American Journal of Orthopsychiatry87(6): 663–670.
30.
KormanBA (2023a) Could classic psychedelics influence immigrants’ acculturation process? A narrative review contemplating how. Drug Science, Policy and Law9. https://doi.org/10.1177/20503245231191400.
31.
KormanBA (2023b) Lifetime classic psychedelic use is associated with greater psychological distress in unemployed job seekers. Journal of Psychedelic Studies. https://doi.org/10.1556/2054.2023.00246.
32.
KormanBA (2023c) Recruitment discrimination of lifetime classic psychedelic users is unjustified: Evidence from employees’ motivation-based workplace absenteeism. Journal of Psychedelic Studies6(3): 203–210.
33.
LichterDTParisiDTaquinoMC (2012) The geography of exclusion: Race, segregation, and concentrated poverty. Social Problems59(3): 364–388.
34.
LongJSFreeseJ (2014) Regression Models for Categorical Dependent Variables Using Stata (3rd ed.). Stata Press.
35.
LongJSMustilloSA (2018) Using predictions and marginal effects to compare groups in regression models for binary outcomes. Sociological Methods & Research50(3): 1284–1320.
36.
LyCGrebACCameronLP, et al. (2018) Psychedelics promote structural and functional neural plasticity. Cell Reports23(11): 3170–3182.
37.
MellnerCDahlenMSimonssonO (2022) Association between lifetime classic psychedelic use and sick leave in a population-based sample. International Journal of Environmental Research and Public Health19(18). https://doi.org/10.3390/ijerph191811353.
38.
MichaelsTIPurdonJCollinsA, et al. (2018) Inclusion of people of color in psychedelic-assisted psychotherapy: A review of the literature. BMC Psychiatry18(1): 45.
39.
MithoeferMCFeducciaAAJeromeL, et al. (2019) MDMA-assisted psychotherapy for treatment of PTSD: Study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. Psychopharmacology236(9): 2735–2745.
40.
National Survey On Drug Use And Hl Survey On Drug Use And Health: Alternative Statistical Models To Predict Mental Illness (2015).
41.
OberfichtnerMTauchmannH (2021) Stacked linear regression analysis to facilitate testing of hypotheses across OLS regressions. The Stata Journal: Promoting Communications on Statistics and Stata21(2): 411–429.
42.
PalamarJJKeyesKM (2020) Trends in drug use among electronic dance music party attendees in New York City, 2016–2019. Drug and Alcohol Dependence209. https://doi.org/10.1016/j.drugalcdep.2020.107889.
43.
PeckR (2021) The Psychedelic Renaissance: a Convergence of Indigenous Knowledge and Science. Portland State University].
44.
PennADorsenCGHopeS, et al. (2021) Psychedelic-Assisted therapy: Emerging treatments in mental health disorders. American Journal of Nursing121(6): 34–40.
45.
PhelanJCLinkBG (2015) Is racism a fundamental cause of inequalities in health?Annual Review of Sociology41: 311–330.
46.
RiggKK (2017) Motivations for using MDMA (ecstasy/Molly) among African Americans: Implications for prevention and harm-reduction programs. Journal of Psychoactive Drugs49(3): 192–200.
47.
RosemanLNuttDJCarhart-HarrisRL (2018) Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Frontiers in Pharmacology8(JAN): 1–10.
48.
RosenfieldS (2012) Triple jeopardy? Mental health at the intersection of gender, race, and class. Social Science & Medicine74(11): 1791–1801.
49.
SimonssonOHendricksPSCarhart-HarrisR, et al. (2021a) Association between lifetime classic psychedelic use and hypertension in the past year. Hypertension: 1510–1516. https://doi.org/10.1161/HYPERTENSIONAHA.120.16715.
50.
SimonssonOHendricksPSChambersR, et al. (2022) Classic psychedelics, health behavior, and physical health. Therapeutic Advances in Psychopharmacology12: 204512532211353.
51.
SimonssonOOsikaWCarhart-HarrisR, et al. (2021b) Associations between lifetime classic psychedelic use and cardiometabolic diseases. Scientific Reports11(1): 10–14.
52.
SimonssonOSextonJDHendricksPS (2021c) Associations between lifetime classic psychedelic use and markers of physical health. Journal of Psychopharmacology35(4): 447–452.
53.
SmithDTFaberSCBuchananNCT, et al. (2022) The need for psychedelic-assisted therapy in the black community and the burdens of its provision. Frontiers in Psychiatry12(JAN): 1–15.
54.
SpencerMSChenJGeeGC, et al. (2010) Discrimination and mental health–related service use in a national study of Asian Americans. American Journal of Public Health100(12): 2410–2417.
55.
StoreyJD (2002) A direct approach to false discovery rates. Journal of the Royal Statistical Society Series B: Statistical Methodology64(3): 479–498.
56.
StoreyJD (2010) False discovery rates multiple hypothesis testing. In: LovricM (eds) International Encyclopedia of Statistical Science.
57.
SudanoJJPerzynskiAWongDW, et al. (2013) Neighborhood racial residential segregation and changes in health or death among older adults. Health and Place19(1): 80–88.
58.
ThrulJGarcia-RomeuA (2021) Whitewashing psychedelics: Racial equity in the emerging field of psychedelic-assisted mental health research and treatment. Drugs: Education, Prevention and Policy28(3): 211–214.
59.
TogiokaBMDuvivierDYoungE (2022) Diversity and Discrimination In Healthcare. StatPearls.
60.
ViñaS (2022, August 6) The harmful relationship between classic psychedelic use and religion on mental health. American Sociological Association 117th Annual Meeting: Bureaucracies of Displacement.
61.
ViñaSM (2024a) Diminished psychedelic returns on distress: Marital status and household size. PLoS ONE19(3): 1–23.
62.
ViñaSM (2024b) Minorities’ diminished psychedelic returns: Cardio-metabolic health. Drug Science, Policy and Law10: 1–13.
ViñaSM (2024d) Minorities’ diminished psychedelic returns: Income and educations impact on whites, Blacks, Hispanics, and Asians. Journal of Race and Ethnic Health Disparities. https://doi.org/10.1007/s40615-024-02023-y.
ViñaSM (2024g). Stigma, psychedelics use, and the risk of reduced formal mental health care. Stigma and Health, Advance Online Pub. https://doi.org/10.1037/sah0000546.
68.
ViñaSMStephensAL (2023a) Minorities’ diminished psychedelic returns. Drug Science, Policy and Law9: 1–19.
69.
ViñaSMStephensAL (2023b) Psychedelics and workplace harm. Frontiers in Psychiatry14(JUNE): –9.
70.
WilliamsDRCollinsC (2001) Racial residential segregation project: A fundamental cause of racial disparities in health. Public Health Reports116(5): 404–416.
71.
YadenDBBerghellaAPRegierPS, et al. (2021) Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs. International Journal of Drug Policy98. https://doi.org/10.1016/j.drugpo.2021.103380.
72.
YonedaAWhealinJMTsaiJ (2015) PTSD In Asian American and pacific islander veterans: Prevalence, context, and implications for practice. In: MartinCPreedyVPatelV (eds) Comprehensive Guide to Post-Traumatic Stress Disorder. Cham: Springer International Publishing, 1–16.
73.
ZeifmanRJSinghalNBreslowL, et al. (2021) On the relationship between classic psychedelics and suicidality: A systematic review. ACS Pharmacology and Translational Science4(2): 436–451.
74.
ZhangZSunKJatchavalaC, et al. (2019) Overview of stigma against psychiatric illnesses and advancements of anti-stigma activities in six Asian societies. International Journal of Environmental Research and Public Health17(1): 280. https://doi.org/10.3390/ijerph17010280.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
